LaMICtal 5 MG Tablet for Oral Suspension

RxCUI: 201239
RxNorm name: LaMICtal 5 MG Tablet for Oral Suspension
Display name: LaMICtal 5 MG Tablet for Oral Suspension
Full name: LaMICtal 5 MG Tablet for Oral Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LAMICTAL	LAMOTRIGINE	GlaxoSmithKline LLC	d7e3572d-56fe-4727-2bb4-013ccca22678	2025-10-10	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 201239

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
d7e3572d-56fe-4727-2bb4-013ccca22678	LaMICtal 5 MG Tablet for Oral Suspension [PSN] · lamotrigine 5 MG Tablet for Oral Suspension [Lamictal] [SBD] · Lamictal CD 5 MG Tablet for Oral Suspension [SY]	3	44	These highlights do not include all the information needed to use LAMICTAL safely and effectively. See full prescribing information for LAMICTAL. LAMICTAL (lamotrigine) tablets, for oral use LAMICTAL (lamotrigine) tablets for oral suspension LAMICTAL ODT (lamotrigine) orally disintegrating tablets, for oral use Initial U.S. Approval: 1994	20251010